382 related articles for article (PubMed ID: 18579209)
1. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE
Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
Sobrin L; Christen W; Foster CS
Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
[TBL] [Abstract][Full Text] [Related]
4. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
Gangaputra SS; Newcomb CW; Joffe MM; Dreger K; Begum H; Artornsombudh P; Pujari SS; Daniel E; Sen HN; Suhler EB; Thorne JE; Bhatt NP; Foster CS; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Kempen JH;
Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine for ocular inflammatory diseases.
Pasadhika S; Kempen JH; Newcomb CW; Liesegang TL; Pujari SS; Rosenbaum JT; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Suhler EB
Am J Ophthalmol; 2009 Oct; 148(4):500-509.e2. PubMed ID: 19570522
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for ocular inflammation.
Daniel E; Thorne JE; Newcomb CW; Pujari SS; Kaçmaz RO; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Foster CS; Jabs DA; Kempen JH
Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate for ocular inflammatory diseases.
Gangaputra S; Newcomb CW; Liesegang TL; Kaçmaz RO; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Kempen JH;
Ophthalmology; 2009 Nov; 116(11):2188-98.e1. PubMed ID: 19748676
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil for the treatment of uveitis.
Teoh SC; Hogan AC; Dick AD; Lee RW
Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
[TBL] [Abstract][Full Text] [Related]
13. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
Waszczyk-Łączak M; Łazicka-Gałecka M; Chomicz L; Mucha K; Pączek L; Szaflik JP
Ann Agric Environ Med; 2020 Dec; 27(4):644-649. PubMed ID: 33356073
[TBL] [Abstract][Full Text] [Related]
14. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.
Baker KB; Spurrier NJ; Watkins AS; Smith JR; Rosenbaum JT
Br J Ophthalmol; 2006 Dec; 90(12):1481-5. PubMed ID: 16914474
[TBL] [Abstract][Full Text] [Related]
15. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic non-infectious uveitis and scleritis.
Rossi DC; Ribi C; Guex-Crosier Y
Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
Tsui E; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Balamurugan S; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan J; Ebert CD; Kim E; Madow B; Porco TC; Acharya NR;
Ophthalmology; 2022 Jun; 129(6):661-667. PubMed ID: 35143800
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.
Browne EN; Rathinam SR; Kanakath A; Thundikandy R; Babu M; Lietman TM; Acharya NR
Ophthalmic Epidemiol; 2017 Feb; 24(1):63-70. PubMed ID: 27982726
[TBL] [Abstract][Full Text] [Related]
19. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
[TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood.
Little JA; Sen ES; Strike H; Hinchcliffe A; Guly CM; Lee RW; Dick AD; Ramanan AV
J Rheumatol; 2014 Jan; 41(1):136-9. PubMed ID: 24085549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
